120 related articles for article (PubMed ID: 24084476)
1. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Oct; 9(10):2033. PubMed ID: 24084476
[No Abstract] [Full Text] [Related]
2. Letter from the Editor.
Ellis R; Weiss A
Hum Vaccin Immunother; 2015; 11(8):1883. PubMed ID: 26260960
[No Abstract] [Full Text] [Related]
3. [Progress of research on DNA vaccines against parasitosis].
Qi WJ; Fang Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):340-4. PubMed ID: 22164511
[TBL] [Abstract][Full Text] [Related]
4. The development of Dengue vaccines. Introduction.
Coller BA; Barrett AD; Thomas SJ
Vaccine; 2011 Sep; 29(42):7219-20. PubMed ID: 21708208
[No Abstract] [Full Text] [Related]
5. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Apr; 9(4):721. PubMed ID: 24091588
[No Abstract] [Full Text] [Related]
6. Antiparasitic DNA vaccines in 21st century.
Wedrychowicz H
Acta Parasitol; 2015 Jun; 60(2):179-89. PubMed ID: 26203983
[TBL] [Abstract][Full Text] [Related]
7. mRNA transcript therapy.
Weissman D
Expert Rev Vaccines; 2015 Feb; 14(2):265-81. PubMed ID: 25359562
[TBL] [Abstract][Full Text] [Related]
8. Moving towards a new class of vaccines for non-infectious chronic diseases.
Chackerian B; Frietze KM
Expert Rev Vaccines; 2016 May; 15(5):561-3. PubMed ID: 26919571
[No Abstract] [Full Text] [Related]
9. IL-13 receptor-directed cancer vaccines and immunotherapy.
Nakashima H; Husain SR; Puri RK
Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
[TBL] [Abstract][Full Text] [Related]
10. Letter from the editor.
Ellis RW; Riedmann EM
Hum Vaccin Immunother; 2012 Jul; 8(7):845. PubMed ID: 22832258
[No Abstract] [Full Text] [Related]
11. DNA vaccines for cancer.
Boyd D; Hung CF; Wu TC
IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
[TBL] [Abstract][Full Text] [Related]
12. New developments in cancer vaccines.
Buonaguro L; Aurisicchio L; Buonaguro FM; Ciliberto G
Expert Rev Vaccines; 2013 Oct; 12(10):1109-10. PubMed ID: 24124872
[No Abstract] [Full Text] [Related]
13. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis.
Ribeiro AM; Bocca AL; Amaral AC; Souza AC; Faccioli LH; Coelho-Castelo AA; Figueiredo F; Silva CL; Felipe MS
Vaccine; 2010 Feb; 28(6):1528-34. PubMed ID: 20045500
[TBL] [Abstract][Full Text] [Related]
14. Dengue virus vaccine development.
Yauch LE; Shresta S
Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
[TBL] [Abstract][Full Text] [Related]
15. Protective DNA vaccination by particle bombardment using BAC DNA containing a replication-competent, packaging-defective genome of herpes simplex virus type I.
Suter M; Hefti HP
Methods Mol Biol; 2004; 256():303-8. PubMed ID: 15024174
[No Abstract] [Full Text] [Related]
16. Therapeutic cancer vaccines: a long and winding road to success.
Baxevanis CN; Papamichail M; Perez SA
Expert Rev Vaccines; 2014 Jan; 13(1):131-44. PubMed ID: 24224539
[TBL] [Abstract][Full Text] [Related]
17. Approaches to immunotherapies for Japanese cedar pollinosis.
Sakaguchi M; Hirahara K; Fujimura T; Toda M
Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607
[TBL] [Abstract][Full Text] [Related]
18. Viral vaccines for bony fish: past, present and future.
Salgado-Miranda C; Loza-Rubio E; Rojas-Anaya E; García-Espinosa G
Expert Rev Vaccines; 2013 May; 12(5):567-78. PubMed ID: 23659303
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches to tuberculosis prevention: DNA vaccines.
Rivas-Santiago B; Cervantes-Villagrana AR
Scand J Infect Dis; 2014 Mar; 46(3):161-8. PubMed ID: 24450840
[TBL] [Abstract][Full Text] [Related]
20. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
Chen CA; Chang MC; Sun WZ; Chen YL; Chiang YC; Hsieh CY; Chen SM; Hsiao PN; Cheng WF
Gene Ther; 2009 Jun; 16(6):776-87. PubMed ID: 19357714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
